Cubist Systematic Strategies’s Enliven Therapeutics ELVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,986
| Closed | -$197K | – | 2474 |
|
|
2023
Q1 | $197K | Buy |
8,986
+5,786
| +181% | +$127K | ﹤0.01% | 2220 |
|
|
2022
Q4 | $52.4K | Buy |
+3,200
| New | +$52.4K | ﹤0.01% | 2938 |
|
|
2021
Q4 | – | Sell |
-2,996
| Closed | -$49K | – | 3503 |
|
|
2021
Q3 | $49K | Buy |
+2,996
| New | +$49K | ﹤0.01% | 2837 |
|